Literature DB >> 18206868

Attenuation of retinal vascular development and neovascularization in PECAM-1-deficient mice.

Terri A Dimaio1, Shoujian Wang, Qiong Huang, Elizabeth A Scheef, Christine M Sorenson, Nader Sheibani.   

Abstract

Platelet-endothelial cell adhesion molecule-1 (PECAM-1/CD31) is expressed on the surface of endothelial cells (EC) at high levels with important roles in angiogenesis and inflammation. However, the physiological role PECAM-1 plays during vascular development and angiogenesis remains largely unknown. Here we determined the role of PECAM-1 in the postnatal development of retinal vasculature and retinal neovascularization during oxygen-induced ischemic retinopathy (OIR) using PECAM-1-deficient (PECAM-1-/-) mice. A significant decrease in retinal vascular density was observed in PECAM-1-/- mice compared with PECAM-1+/+ mice. This was attributed to a decreased number of EC in the retinas of PECAM-1-/- mice. An increase in the rate of apoptosis was observed in retinal vessels of PECAM-1-/- mice, which was compensated, in part, by an increase in the rate of proliferation. However, the development and regression of hyaloid vasculature were not affected in the absence of PECAM-1. We did not observe a significant defect in astrocytes, the number of endothelial tip cell filopodias, and the rate of developing retinal vasculature progression in PECAM-1-/- mice. However, we observed aberrant organization of arterioles and venules, decreased secondary branching, and dilated vessels in retinal vasculature of PECAM-1-/- mice. In addition, retinal neovascularization was attenuated in PECAM-1-/- mice during OIR despite an expression of VEGF similar to that of PECAM-1+/+ mice. Mechanistically, these changes were associated with an increase in EphB4 and ephrin B2, and a decrease in eNOS, expression in retinal vasculature of PECAM-1-/- mice. These results suggest that PECAM-1 expression and its potential interactions with EphB4/ephrin B2 and eNOS are important for survival, migration, and functional organization of EC during retinal vascular development and angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18206868      PMCID: PMC2275901          DOI: 10.1016/j.ydbio.2007.12.008

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  51 in total

1.  Role of PECAM-1 in the shear-stress-induced activation of Akt and the endothelial nitric oxide synthase (eNOS) in endothelial cells.

Authors:  Ingrid Fleming; Beate Fisslthaler; Madhulika Dixit; Rudi Busse
Journal:  J Cell Sci       Date:  2005-08-23       Impact factor: 5.285

2.  EphB4 controls blood vascular morphogenesis during postnatal angiogenesis.

Authors:  Ralf Erber; Uta Eichelsbacher; Violetta Powajbo; Tobias Korn; Valentin Djonov; Jihong Lin; Hans-Peter Hammes; Rainer Grobholz; Axel Ullrich; Peter Vajkoczy
Journal:  EMBO J       Date:  2006-01-19       Impact factor: 11.598

3.  Soluble EphB4 regulates choroidal endothelial cell function and inhibits laser-induced choroidal neovascularization.

Authors:  Shikun He; Yi Ding; Jiehao Zhou; Valery Krasnoperov; Sergey Zozulya; S Ram Kumar; Stephen J Ryan; Parkash S Gill; David R Hinton
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-12       Impact factor: 4.799

4.  Endothelial nitric oxide synthase is critical for ischemic remodeling, mural cell recruitment, and blood flow reserve.

Authors:  Jun Yu; Ebo D deMuinck; Zhenwu Zhuang; Mary Drinane; Katalin Kauser; Gabor M Rubanyi; Hu Sheng Qian; Takahisa Murata; Bruno Escalante; William C Sessa
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-25       Impact factor: 11.205

5.  EphB ligand, ephrinB2, suppresses the VEGF- and angiopoietin 1-induced Ras/mitogen-activated protein kinase pathway in venous endothelial cells.

Authors:  Injune Kim; Young Shin Ryu; Hee Jin Kwak; So Young Ahn; Jong-Lark Oh; George D Yancopoulos; Nicholas W Gale; Gou Young Koh
Journal:  FASEB J       Date:  2002-05-21       Impact factor: 5.191

6.  Peroxynitrite reduces the endothelium-derived hyperpolarizing factor component of coronary flow-mediated dilation in PECAM-1-knockout mice.

Authors:  Yanping Liu; Aaron H Bubolz; Yang Shi; Peter J Newman; Debra K Newman; David D Gutterman
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2005-09-15       Impact factor: 3.619

7.  Lack of platelet endothelial cell adhesion molecule-1 attenuates foreign body inflammation because of decreased angiogenesis.

Authors:  Anna Solowiej; Purba Biswas; Donnasue Graesser; Joseph A Madri
Journal:  Am J Pathol       Date:  2003-03       Impact factor: 4.307

8.  EndoCAM: a novel endothelial cell-cell adhesion molecule.

Authors:  S M Albelda; P D Oliver; L H Romer; C A Buck
Journal:  J Cell Biol       Date:  1990-04       Impact factor: 10.539

9.  PECAM-1 interacts with nitric oxide synthase in human endothelial cells: implication for flow-induced nitric oxide synthase activation.

Authors:  N Dusserre; N L'Heureux; K S Bell; H Y Stevens; J Yeh; L A Otte; L Loufrani; J A Frangos
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-07-29       Impact factor: 8.311

10.  Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4.

Authors:  H U Wang; Z F Chen; D J Anderson
Journal:  Cell       Date:  1998-05-29       Impact factor: 41.582

View more
  34 in total

1.  Opposing effects of bim and bcl-2 on lung endothelial cell migration.

Authors:  Cathy Grutzmacher; SunYoung Park; Tammy L Elmergreen; Yixin Tang; Elizabeth A Scheef; Nader Sheibani; Christine M Sorenson
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-07-23       Impact factor: 5.464

2.  Altered vascular expression of EphrinB2 and EphB4 in a model of oxygen-induced retinopathy.

Authors:  Michael H Davies; Andrew J Stempel; Kristin E Hubert; Michael R Powers
Journal:  Dev Dyn       Date:  2010-06       Impact factor: 3.780

3.  Mesangial cell integrin αvβ8 provides glomerular endothelial cell cytoprotection by sequestering TGF-β and regulating PECAM-1.

Authors:  Shenaz Khan; Sujata Lakhe-Reddy; Joseph H McCarty; Christine M Sorenson; Nader Sheibani; Louis F Reichardt; Jane H Kim; Bingcheng Wang; John R Sedor; Jeffrey R Schelling
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

Review 4.  Cell biology of embryonic migration.

Authors:  Satoshi Kurosaka; Anna Kashina
Journal:  Birth Defects Res C Embryo Today       Date:  2008-06

Review 5.  PECAM-1 isoforms, eNOS and endoglin axis in regulation of angiogenesis.

Authors:  Sunyoung Park; Christine M Sorenson; Nader Sheibani
Journal:  Clin Sci (Lond)       Date:  2015-08       Impact factor: 6.124

6.  PECAM-1 regulates proangiogenic properties of endothelial cells through modulation of cell-cell and cell-matrix interactions.

Authors:  SunYoung Park; Terri A DiMaio; Elizabeth A Scheef; Christine M Sorenson; Nader Sheibani
Journal:  Am J Physiol Cell Physiol       Date:  2010-09-01       Impact factor: 4.249

Review 7.  PECAM-1: regulator of endothelial junctional integrity.

Authors:  Jamie R Privratsky; Peter J Newman
Journal:  Cell Tissue Res       Date:  2014-01-17       Impact factor: 5.249

8.  Angiogenesis in platelet endothelial cell adhesion molecule-1-null mice.

Authors:  Gaoyuan Cao; Melane L Fehrenbach; James T Williams; Jeffrey M Finklestein; Jing-Xu Zhu; Horace M Delisser
Journal:  Am J Pathol       Date:  2009-07-02       Impact factor: 4.307

9.  Skeletal overexpression of connective tissue growth factor impairs bone formation and causes osteopenia.

Authors:  Anna Smerdel-Ramoya; Stefano Zanotti; Lisa Stadmeyer; Deena Durant; Ernesto Canalis
Journal:  Endocrinology       Date:  2008-06-05       Impact factor: 4.736

10.  EC-18, a synthetic monoacetyldiacylglyceride, inhibits hematogenous metastasis of KIGB-5 biliary cancer cell in hamster model.

Authors:  Myung-Hwan Kim; Heung Moon Chang; Tae Won Kim; Sung Koo Lee; Jung-Sun Park; Young-Hoon Kim; Tae Yoon Lee; Se Jin Jang; Chul-Won Suh; Tae-Suk Lee; Sang-Hee B Kim; Sung-Gyu Lee
Journal:  J Korean Med Sci       Date:  2009-06-12       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.